Faq category: Immunoassay

Why should our company partner with you for immunoassay development services?

Your company benefits from a highly experienced development team, access to specialized lab infrastructure, and a proven workflow that minimizes risk and accelerates progress. We combine scientific expertise with strong project management to deliver reliable immunoassays that are ready for scale-up, regulatory review, and commercial use.  

What is included in your development and validation process for immunoassays?

Our development and validation process covers all critical steps: reagent selection, assay optimization, analytical validation, verification with clinical samples, documentation, and transfer into production. Each phase is performed under strict quality standards to ensure accuracy, reproducibility, and regulatory readiness.

How does your contract model work for immunoassay development projects?

Projects are executed under a clear contract that defines scope, timelines, deliverables, intellectual property, and budget. This structure ensures transparency from the start and allows your project to progress efficiently while maintaining flexibility for scientific or technical adjustments when needed.

Do you offer custom development for new or complex immunoassays?

Yes. We provide full custom development for both new and existing immunoassays, including feasibility testing, assay design, optimization, and performance evaluation. Our team tailors every step to your specific biomarker, platform, and end-user requirements, ensuring a robust and scalable solution.

What types of immunoassays does Future Diagnostics develop?

We develop a broad range of immunoassays, including ELISA (direct, indirect, sandwich, competitive ELISA), Chemiluminescence Immunoassay (CLIA), Point of Care, lateral flow, microarray, and multiplex assays. These are customized for applications in cardiology, oncology, fertility, infectious diseases, autoimmunity, and other disease areas. Whether for diagnostic automated platforms, point-of-care devices, or manual research tools, our…